Literature DB >> 24947893

Incorporation of apical lymph node status into the seventh edition of the TNM classification improves prediction of prognosis in stage III colonic cancer.

H Kawada1, N Kurita, F Nakamura, J Kawamura, S Hasegawa, K Kotake, K Sugihara, S Fukuhara, Y Sakai.   

Abstract

BACKGROUND: The node classification outlined in the seventh edition of the TNM classification is based solely on the number of metastasized lymph nodes. This study examined the prognostic value of apical lymph node (ALN) metastasis and the additional value of incorporating ALN status into a risk model based on the seventh edition.
METHODS: This was a cohort study of patients with stage III colonic cancer who underwent tumour resection with dissection of regional (including apical) lymph nodes at 71 hospitals across Japan between 2000 and 2002. The main exposure was pathologically confirmed ALN metastasis, and the primary endpoint was cancer-specific death.
RESULTS: ALN metastasis was present in 113 (8·3 per cent) of 1355 patients. During 5356 patient-years of follow-up (median 5·0 years), 221 instances (16·3 per cent) of cancer-specific death were observed. After adjustment for tumour and node classification (as described in the seventh edition of the TNM classification) and other prognostic factors, ALN metastasis was found to be independently associated with cancer-specific death (hazard ratio 2·29, 95 per cent confidence interval (c.i.) 1·49 to 3·52). Incorporation of ALN metastasis into the prognostic model based on the seventh edition of the TNM classification significantly improved discriminative performance for cancer-specific death (difference in concordance index 0·0146, 95 per cent c.i. 0·0030 to 0·0262) and risk reclassification for cancer-specific death at 5 years (category-free net reclassification improvement 19·4 (95 per cent c.i. 5·0 to 33·4) per cent).
CONCLUSION: Assessment of ALN metastasis provided independent prognostic information beyond that achievable with the seventh edition of the TNM classification in patients with stage III colonic cancer.
© 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24947893     DOI: 10.1002/bjs.9548

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

Review 1.  Management of nodal disease from colon cancer in the laparoscopic era.

Authors:  Corrado Pedrazzani; Lelde Lauka; Simone Sforza; Andrea Ruzzenente; Filippo Nifosì; GianGaetano Delaini; Alfredo Guglielmi
Journal:  Int J Colorectal Dis       Date:  2014-11-22       Impact factor: 2.571

2.  Apical Lymph Nodes in the Distant Metastases and Prognosis of Patients with Stage III Colorectal Cancer with Adequate Lymph Node Retrieval Following FOLFOX Adjuvant Chemotherapy.

Authors:  Hsiang-Lin Tsai; Yi-Ting Chen; Yung-Sung Yeh; Ching-Wen Huang; Cheng-Jen Ma; Jaw-Yuan Wang
Journal:  Pathol Oncol Res       Date:  2018-01-03       Impact factor: 3.201

3.  Metastasis to lymph nodes around the vascular tie worsens long-term oncological outcomes following complete mesocolic excision and conventional colectomy for right-sided colon cancer.

Authors:  Serkan Zenger; Erman Aytac; Bulent Gurbuz; Volkan Ozben; Emre Ozoran; Bilgi Baca; Emre Balik; Ismail Hamzaoglu; Tayfun Karahasanoglu; Dursun Bugra
Journal:  Tech Coloproctol       Date:  2021-01-05       Impact factor: 3.781

4.  Mid-term oncological outcomes after complete versus conventional mesocolic excision for right-sided colon cancer: a propensity score matching analysis.

Authors:  Alessandro Giani; Camillo Leonardo Bertoglio; Michele Mazzola; Irene Giusti; Pietro Achilli; Pietro Carnevali; Matteo Origi; Carmelo Magistro; Giovanni Ferrari
Journal:  Surg Endosc       Date:  2022-01-13       Impact factor: 3.453

5.  Performance of a Nomogram Based on the Integration of Inflammation Markers with Tumor Staging in Prognosis Prediction of Stage III Colorectal Cancer.

Authors:  Lin Wang; Jun Xiao; Min-Zhe Li; Wen-Hao Teng; Jing Jia; Lu Lin; Sheng Liu; Xing-Ming Ye; Wei-Dong Zang; Ying Chen
Journal:  Cancer Manag Res       Date:  2020-08-07       Impact factor: 3.989

6.  Prognostic Utility of Apical Lymph Node Metastasis in Patients With Left-sided Colorectal Cancer.

Authors:  Liming Wang; Yasumitsu Hirano; Gregory Heng; Toshimasa Ishii; Hiroka Kondo; Kiyoka Hara; Nao Obara; Masahiro Asari; Shigeki Yamaguchi
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

7.  The role of apical lymph node metastasis in right colon cancer.

Authors:  Li M Wang; Yasu M Hirano; Toshi M Ishii; Hiro K Kondo; Kiyo K Hara; Nao Obara; Masa H Asari; Shige K Yamaguchi
Journal:  Int J Colorectal Dis       Date:  2020-06-08       Impact factor: 2.571

8.  The prognostic significance of apical lymph node metastasis in patients with high-risk stage III colon cancer.

Authors:  Kenichi Ishii; Jun Watanabe; Kouki Goto; Yusuke Suwa; Kazuya Nakagawa; Hirokazu Suwa; Mayumi Ozawa; Atsushi Ishibe; Chikara Kunisaki; Itaru Endo
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.379

9.  Apical lymphadenectomy during low ligation of the IMA during rectosigmoid resection for cancer.

Authors:  Keegan Guidolin; Andrea Covelli; Tyler R Chesney; Arman Draginov; Sami A Chadi; Fayez A Quereshy
Journal:  Surg Open Sci       Date:  2021-06-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.